Company news

Stereotaxis, Inc. (AMEX:STXS) news

Every Stereotaxis, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Stereotaxis, Inc. stock analysis →

Press releases & updates

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

August 11, 2026

Stereotaxis Completes Acquisition of Robocath

July 9, 2026

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

May 12, 2026

Stereotaxis Announces First MAGiC Procedures in the United States

April 22, 2026

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

April 21, 2026

Stereotaxis Announces Definitive Agreement to Acquire Robocath

April 15, 2026

Stereotaxis Announces FDA Clearance and Launch of Synchrony System

April 6, 2026

Stereotaxis Reports 2025 Full Year Financial Results

March 9, 2026

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

February 12, 2026

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

February 9, 2026

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

January 6, 2026

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

November 24, 2025

Stereotaxis Reports 2025 Third Quarter Financial Results

November 11, 2025

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

November 10, 2025

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

October 21, 2025

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

October 15, 2025

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

October 13, 2025

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

September 22, 2025

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

September 2, 2025

Stereotaxis to Present at Upcoming Investor Conferences

September 2, 2025

Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025

August 28, 2025

Stereotaxis Reports 2025 Second Quarter Financial Results

August 7, 2025

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

July 28, 2025

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

July 23, 2025

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

July 17, 2025

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

July 1, 2025

Stereotaxis Reports 2025 First Quarter Financial Results

May 12, 2025